The present disclosure relates to transparent bacterial-derived cellulose-based materials, and methods and kits for making and using the same.
Bacterial-derived cellulose has become a prominent material for biomedical research applications due to its ease of fabrication, biocompatibility, high yield strength, and water retention properties. Optical transparency, however, has not been consistently observed in pure bacterial-derived cellulose and has predominantly been achieved through the addition of composite materials or coatings. Increased transparency of the bacterial-derived cellulose would allow for a broader range of biomaterial applications, such as wound dressing, corneal tissue engineering, and biosensing. Existing chemical modification and composite formation techniques for cellulosic materials have been employed to formulate water soluble or highly swollen cellulose that then gives rise to optically clear properties. Past approaches to produce optically clear cellulose include the use of polyurethane and poly(2-hydroxyethyl methacrylate) and composite materials or chemical conversion of cellulose to hydroxymethylcellulose. New approaches that minimize steps to synthesize optically transparent films and reduce or eliminate costly or toxic chemical reactions are urgently needed.
As described below, the present disclosure features transparent bacterial-derived cellulose-based materials, for example, pellicles, films, and hydrogels.
In some aspects of the present disclosure, a method is provided for preparing a transparent bacterial-derived cellulose-based material that comprises culturing cellulose-producing bacteria in a media comprising a non-glucose carbon source and collecting cellulose-based material produced by the cellulose-producing bacteria, wherein the cellulose-based material has a light transmission of at least 50% of light energy having a wavelength between 400 nm and 600 nm. In some embodiments, the media further comprises glucose. In some embodiments, the non-glucose carbon source comprises one or more of a pentose sugar, a hexose sugar, a sugar alcohol, or a disaccharide. In some embodiments, the pentose sugar is selected from the group consisting of xylose and arabinose. In some embodiments, the hexose sugar is selected from the group consisting of mannose, galactose, fructose, glucosamine hydrochloride, and N-acetylglucosamine. In some embodiments, the sugar alcohol is selected from the group consisting of arabitol and mannitol. In some embodiments, the disaccharide is sucrose. In some embodiments, the non-glucose carbon source comprises one or more of mannose, galactose, xylose, mannitol, sucrose, glucosamine hydrochloride, N-acetylglucosamine, fructose, arabinose, and arabitol. In some embodiments, the non-glucose carbon source comprises one or more of arabitol and xylose. In some embodiments, the cellulose-producing bacteria comprises bacteria from Acetobacter genus. In some embodiments, the cellulose-producing bacteria comprises one or more of DS-12, Gluconacetobacter hansenii, or Gluconacetobacter xylinus bacterial species. In some embodiments, the bacterial-derived cellulose-based material has a light transmission of at least 75% of light energy having a wavelength between 400 nm and 600 nm. In some embodiments, the oxygen tension is reduced relative to ambient. In some embodiments, the non-glucose carbon source is selected to produce increased cyclic di-GMP levels in the cellulose-producing bacteria. In some embodiments, the cellulose-producing bacteria is cultured without glucose.
In some aspects of the present disclosure, a material is provided for biomedical application comprising bacterial-derived cellulose-based material having a light transmission of at least 50% of light energy having a wavelength between 400 nm and 600 nm.
In some aspects of the present disclosure, a kit is provided for preparing a transparent bacterial-derived cellulose-based material comprising cellulose-producing bacteria, and one or more non-glucose carbon sources, wherein culturing the cellulose-producing bacteria in the presence of the one or more non-glucose carbon source produces cellulose-based material having a light transmission of at least 50% of light energy having a wavelength between 400 nm and 600 nm. In some embodiments, the cellulose-producing bacteria comprises bacteria from Acetobacter genus. In some embodiments, the cellulose-producing bacteria comprises one or more of DS-12, Gluconacetobacter hansenii, or Gluconacetobacter xylinus bacterial species. In some embodiments, the non-glucose carbon source comprises one or more of mannose, galactose, xylose, mannitol, sucrose, glucosamine hydrochloride, N-acetylglucosamine, fructose, arabinose, and arabitol.
The present disclosure will be described in the detailed description which follows, in reference to the noted plurality of drawings by way of non-limiting examples of exemplary embodiments, in which like reference numerals represent similar parts throughout the several views of the drawings, and wherein:
While the above-identified drawings set forth presently disclosed embodiments, other embodiments are also contemplated, as noted in the discussion. This disclosure presents illustrative embodiments by way of representation and not limitation. Numerous other modifications and embodiments can be devised by those skilled in the art which fall within the scope and spirit of the principles of the presently disclosed embodiments.
The present disclosure provides transparent bacterial-derived cellulose-based materials. In some embodiments, such materials can be derived from one or more cellulose-producing bacteria provided with one or more non-glucose carbon sources, with or without glucose.
The methods described herein allow for the formation of naturally synthesized, optically clear materials composed of pure cellulose, or combinations of cellulose and other polysaccharides. In some embodiments, the term “cellulose” refers to a polymer comprising β(1→4) linked D-glucose monomers. Cellulose is primarily derived from plant origin and is the structural component of plant cell walls and fibers of cotton, for example. Cellulose can also be bacterial-derived, and such cellulose may require minimal processing. A representative structure of cellulose is as follows:
Transparent cellulose-based hydrogels have been described previously; however, fabricating these hydrogels required cross-linking or other chemical modifications. For example, transparent hydrogels have been reported that were fabricated by cross-linking 2-hydroxyethyl methacrylate (PHEMA) with bacterial-derived cellulose (see U.S. Patent Application Publication No. 20130011385). Importantly, the transparent cellulose-based materials of the present disclosure do not require additional chemical processing beyond purification (i.e., the removal of microbial components) to achieve optically transparency. In some embodiments, purification can be accomplished using methods well known in the art.
In reference to
The cellulose-based materials of the present disclosure can be presented in various forms. For example, the cellulose-based materials can be presented in a form of a pellicle, fiber, membrane, film, block or hydrogel. For example, the term “pellicle” can refer to a thin skin or membrane produced by cellulose-producing bacteria. In some embodiments, the pellicle can be used to manufacture a film (dried) or hydrogel (hydrated).
The properties of the bacterial-derived transparent cellulose-based materials of the present disclosure can be particularly well suited for the use in various biomedical application where transparent materials are commonly used. In general, the bacterial-derived transparent cellulose-based materials can include one or more properties selected from: high crystallinity; high degree of polymerization; biocompatibility; high flexibility; high tensile strength; high water holding capacity; have modular shape. Transparent bacterial-derived cellulose-based materials can be used to manufacture inexpensive materials for biomedical applications. For example, transparent films made from the bacterial-derived cellulose can be used for wound dressing visualization, biosensing, and corneal tissue engineering. The modular optical clarity allows the bacterial cellulose of the present disclosure to be used for tissue engineering applications where transparent films are required (e.g., corneal tissue engineering and biosensing). Optically transparent materials can be used for wound dressings, which allow for visualization of healing without the need to disrupt the wound site.
The bacterial-derived cellulose-based materials of the present disclosure are transparent or optically clear. Transparent bacterial-derived cellulose-based materials, for example, pellicles, films, and hydrogels are described by their ability to allow light to pass through as determined by ultraviolet-visible (UV-Vis) light spectroscopy.
In some embodiments, light transmission through a material in the visible light region between 400 nm and 700 nm can be used to determine transparency or increased transparency as compared to materials synthesized under standard conditions (for example, glucose-only carbon source as will be described below).
The cellulose based materials of the present are transparent or optically clear. The term “transparent” or “optically clear” is meant that these materials allow a transmission of light energy. For example, the term “transmittance” may refer to the light passing through a sample, while the term “transparency” can refers to the property of the material. In some embodiments, the value of light transmission through the material (or transmittance) is above 50% across the visible light spectrum. In some embodiments, the presently disclosed materials have the value of light transmission above 75% or between 75% and 100%. In some embodiments, the presently disclosed materials have the value of light transmission above 80% or between 80% and 100%. In some embodiments, the presently disclosed materials have the value of light transmission above 85% or between 85% and 100%. In some embodiments, the presently disclosed materials have the value of light transmission above 90% or between 95% and 100%. In various embodiments, the presently disclosed materials have the value of light transmission between 75% and 95%, 75% and 90%, 75% and 85%; 75% and 80%, 80% and 95%, 80% and 90%, 80% and 85%; 85% and 95%, 85% and 90%; 90% and 100% or 95% and 100%. In some embodiments, the transparency of the presently disclosed material is described in terms of % improvement over a standard cellulose material. Such improvement can be, for example, between 25-50% improvement, 50-100% improvement, 100-200% improvement, 200-300% improvement, or greater than 300% improvement. In some embodiments, the value of light transmission is measured with light energy having a wavelength between about 400 nm and about 600 nm.
In reference to
The transparent cellulose-based materials of the present disclosure can be produced by various cellulose-producing bacterial species. In some embodiments, the cellulose-producing bacteria is from an Acetobacter or Komagataeibacter genus. One or more cellulose producing strains of bacteria from Acetobacter or Komagataeibacter genus can be used. For example, in some embodiments, the cellulose-producing bacteria may be one or more of an isolated strain labeled as DS-12 (
In reference to
In some embodiments, the transparent cellulose-based material disclosed herein are achieved by altering the carbon source used in the media culture. In some embodiments, a carbon source other than glucose can be used in the media culture. Such alternative carbon sources can be referred to as a non-glucose carbon source. In some embodiments, the non-glucose carbon source is a carbon source free of glucose. In some embodiments, the alternative carbon sources may include monosaccharides or disaccharides and may be selected from sugars or sugar alcohols. In some embodiments, the alternative, or non-glucose carbon sources include, but are not limited to, mannose, mannitol, galactose, xylose, sucrose, glucosamine hydrochloride (GlcN.HCl), N-acetylglucosamine (GlcNAc), fructose, L-arabinose, D-arabitol or combinations thereof. In some embodiments, the alternative carbon sources include, but are not limited to, pentose sugars, for example, xylose or arabinose. In some embodiments, the alternative carbon sources include, but are not limited to, hexose sugars, for example, mannose, galactose, fructose, glucosamine hydrochloride (GlcN.HCl), or N-acetylglucosamine (GlcNAc). In some embodiments, the alternative carbon sources include, but are not limited to, sugar alcohols, for example, arabitol or mannitol. In some embodiments, the alternative carbon sources include, but are not limited to, disaccharide sugars, for example, sucrose. In some embodiments, the alternative carbon source can include a combination of non-glucose carbon sources. In some embodiments, only non-glucose carbon sources can be used. In some embodiments, glucose can be used in combination with one or more non-glucose carbon sources.
In reference to
In some embodiments, the transparent cellulose-based materials disclosed herein are achieved by altering the oxygen tension (i.e., partial pressure of oxygen). In some embodiments, the transparent cellulose-based materials are produced by culturing cellulose-producing bacteria under oxygen conditions lower than ambient oxygen (e.g. within a closed container). In some embodiments, the transparent pellicles, films, and hydrogels display higher transmission % relative to those produced at ambient oxygen conditions (
Ranges provided herein are understood to be shorthand for all of the values within the range. For example, a range of 1 to 50 is understood to include any number, combination of numbers, or sub-range from the group consisting 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50.
Unless specifically stated or obvious from context, as used herein, the term “or” is understood to be inclusive. For example, “or” can be understood to be either one of the elements, all of the elements, or any combination thereof. Unless specifically stated or obvious from context, as used herein, the terms “a,” “an,” and “the” are understood to be singular or plural.
Unless specifically stated or obvious from context, as used herein, the term “about” is understood as within a range of normal tolerance in the art, for example within 2 standard deviations of the mean. About can be understood as within 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.05%, or 0.01% of the stated value. Unless otherwise clear from context, all numerical values provided herein are modified by the term about.
Any compositions or methods provided herein can be combined with one or more of any of the other compositions and methods provided herein.
The following examples are put forth so as to provide those of ordinary skill in the art with a complete disclosure and description of how to make and use the assay, screening, and therapeutic methods of the disclosure, and are not intended to limit the scope of what the inventors regard as their disclosure.
In some embodiments, the isolation of cellulose-producing bacterial strains can be accomplished by growing bacteria derived from a pellicle-producing culture on a black tea agar plate. For example, bacterial colonies growing on the plate can then be streaked onto a Hestrin-Schramm (HS) Agar plate. Colonies can then be further grown in HS media and tested for their ability to form a pellicle in static culture. An example of this process is shown in
A home brewed kombucha pellicle, originally sourced from Urban Farm (Portland, Me.), was streaked onto a black tea agar plate (2 mg/mL steeped black tea was sterile filtered and supplemented with 40 mg/mL sucrose, 10% (v/v) kombucha starter, and 15 mg/mL agar) and allowed to grow at 30° C. for 4 days. Cellulose production was observed in specific colonies grown on the black tea plate. A single cellulose-producing colony was picked and restreaked on a Hestrin-Schramm media (HS) agar plate (20 mg/mL glucose, 5 mg/mL peptone, 5 mg/mL yeast extract, 1.15 mg/mL citric acid, 2.7 mg/mL disodium phosphate, 15 mg/mL agar) and allowed to grow at 30° C. for an additional 4 days. Single colonies from the HS plate were used to inoculate 5 mL of HS medium (20 mg/mL glucose, 5 mg/mL peptone, 5 mg/mL yeast extract, 1.15 mg/mL citric acid, 2.7 mg/mL disodium phosphate) media in 14 mL Falcon round cell culture tubes and allowed to grow on a rotating drum for 4 days at 30° C. Cellulose production ability was confirmed, and the isolated strain was labeled DS-12.
A cellulose-producing bacterial strain isolated from a home brewed kombucha pellicle DS-12 (Urban Farm Portland, Me.), Gluconacetobacter xylinus (ATCC 10245), and Gluconacetobacter hansenii (ATCC 53582) were colony picked into 5 mL of Hestrin-Schramm (HS) medium and incubated for 4 days on a shaker at 30° C. Static cultures were expanded using 10% (v/v) inoculum with the remaining being fresh medium. For experiments, fresh HS medium without glucose or mannitol was inoculated with 0.1% (v/v) static cultured bacteria. The media was supplemented to 1 mM of each carbon source under investigation (glucose, mannose, galactose, xylose, mannitol, sucrose, glucosamine hydrochloride (GlcN.HCl), N-acetylglucosamine (GlcNAc), fructose, L-arabinose, D-arabitol, and combinations thereof).
In some embodiments, cellulose purification can be by any purification method known in the art. In some embodiments, cellulose purification can be by the method described in
In some embodiments, the growth kinetics and cellulose yields can be characterized, for example, according to the protocol in the diagram shown in
In some embodiments, a growth kinetics curve for glucose-derived cellulose can be determined.
Optical density is used to determine bacterial population growth. These cultures were grown with cellulase preventing the cellulose pellicle from forming. As the bacterial population increased, the optical density of the culture increased. Optical density is determined using a visible light source plate reader that uses a light source at 600 nm and a light detector.
In some embodiments, the maximum growth rate for cultures grown in media comprising different carbon sources can be determined and displayed as shown in
In some embodiments, the yield % for cultures grown in media comprising different carbon sources can be determined and displayed as shown in
In some embodiments, alternative carbon sources (mannose, galactose, xylose) provide increased transparency as compared to glucose as demonstrated in three cellulose-producing strains (DS-12, G. xylinus, G. hansenii) as shown in
In some embodiments, cellulose pellicles were grown in 12-well plates under static conditions at 30° C. for 7 days. Pellicles were harvested, washed in 0.1 M NaOH at 60° C. for 4 hours, and then rinsed with DI H2O until the samples reached a neutral pH.
In some embodiments, pellicles were measured for overall light transmission in the visible light region using UV-Vis Spectrometry (Thermo Evolution 300 UV-Vis). For example,
In some embodiments, glucose may be combined with an alternative carbon source. In some embodiments, increasing the percentage of glucose decreases the percent transmittance of light in a culture sample (see
Mixtures of alternative carbon sources with glucose were also tested and both DS-12 and G. xylinus showed preferential metabolism of glucose. A decrease in transparency was also observed when glucose was introduced as a carbon source, while xylose, mannose, fructose, galactose, sucrose, arabitol and arabinose produced highly transparent pellicles.
From the foregoing description, it will be apparent that variations and modifications may be made to the disclosure described herein to adopt it to various usages and conditions. Such embodiments are also within the scope of the following claims.
The recitation of a listing of elements in any definition of a variable herein includes definitions of that variable as any single element or combination (or subcombination) of listed elements. The recitation of an embodiment herein includes that embodiment as any single embodiment or in combination with any other embodiments or portions thereof.
All patents and publications mentioned in this specification are herein incorporated by reference to the same extent as if each independent patent and publication was specifically and individually indicated to be incorporated by reference.
This application claims the benefit of and the priority to U.S. Provisional Patent Application Ser. No. 62/916,649, filed Oct. 17, 2019, the entire disclosure of which is herein incorporated by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
62916649 | Oct 2019 | US |